Pharmakokinetische Prinzipien der Arzneimitteltherapie

  • D. Trenk
  • E. Jähnchen

Zusammenfassung

Nach intravasaler Injektion oder nach abgeschlossener Resorption wird die Konzentration eines Arzneimittels in der systemischen Zirkulation durch 2 pharmakokinetische Prozesse bestimmt: Verteilung und Elimination.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Collste, P., Haglund, K., Von Bahr, C.: Plasma levels and effects of metoprolol after single and multiple oral doses. Clin. Pharmacol. Ther. 27, 441–449 (1980).PubMedCrossRefGoogle Scholar
  2. Duff, H., Roden, D., Brorson, L., Wood, A., Dawson, A., Primm, K., Oates, J. , Smith, R., Woosley, R.: Electrophysiologic actions of high plasma concentrations of propranolol in human subjects. J. Amer. Coll. Cardiol. 2, 1134–1140 (1983).CrossRefGoogle Scholar
  3. Eichelbaum, M.: Defective oxidation of drugs: Pharmacokine-tic and therapeutic implications. Clin. Pharmacokin. 7, 1–22 (1982).CrossRefGoogle Scholar
  4. Eichelbaum, M., Echizen, H., Vogelsang, B.: Einfluß der Applikationsart auf die Plasmakonzentrations-Wirkung von Pharmaka. In: Plasmaspiegel-Wirkungsbeziehung von Pharmaka (Frölich, J.C., Hrsg.), S. 7–13. Stuttgart-New York, Gustav Fischer 1986.Google Scholar
  5. Galeazzi, R.L., Benet, L.Z., Sheiner, L.B.: Relationship between the pharmacokinetics and pharmacodynamics of procainamide. Clin. Pharmacol. Ther. 20, 278–289 (1976).PubMedGoogle Scholar
  6. Hill, A. V.: The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves. J. Physiol. 40, 4 (1910).Google Scholar
  7. Holford, N.H.G., Sheiner L.B.: Kinetics of pharmacologic response. Pharmacol. Ther. 16, 143–166 (1982).PubMedCrossRefGoogle Scholar
  8. Jähnchen, E., Bechtold, H., Kasper, W., Kersting, F., Just, H.J., Heykants, J., Meinertz, T.: Lorcainide I. Saturable presystemic elimination. Clin. Pharmacol. Ther. 26, 187–195 (1979).PubMedGoogle Scholar
  9. Koch-Weser, J.: In: Pharmacology And The Future: Problems In Therapy ( Okita, G.T., Archeseon, G.H. (Hrsg.), S. 69–85. Basel: Karger (1973).Google Scholar
  10. Levy, G.: Kinetics of pharmacologic effects. Clin. Pharmacol. Ther. 7, 362–372 (1966).PubMedGoogle Scholar
  11. Levy, G., O’reilly, R.A., Aggeler, P.M., Keech, G.M.: Pharmacokinetic analysis of the effect of barbiturate on the anticoagulant action of warfarin in man. Clin. Pharmacol. Ther. 11, 372–377 (1970).PubMedGoogle Scholar
  12. Meinertz, T., Kasper, W., Kersting, F., Just, H. J., Bechtold, H., Jähnchen, E.: Lorcainide, II. Plasma concentra- tion-effect relationship. Clin. Pharmacol. Ther. 26, 196–204 (1979).PubMedGoogle Scholar
  13. Meinertz, T., Brandstätter, A., Trenk, D., Jähnchen, E., Ostrowski, J., Gärtner, W.: Relationship between pharmacokinetics and pharmacodynamics of molsidomine and its metabolites in humans. Amer. Heart J. 109, 644–648 (1985).PubMedCrossRefGoogle Scholar
  14. Nagashima, R., O’reilly, R. A., Levy, F.: Kinetics of pharmacologic effects in man: The anticoagulant action of warfarin. Clin. Pharmacol. Ther. 10, 22–35 (1969).PubMedGoogle Scholar
  15. Rowland, M., Tozer, T.N.: Clinical pharmacokinetics: Con-cepts and applications. Philadelphia: Lea & Febiger 1980.Google Scholar
  16. Schmidt, W., Jähnchen, E.: Interaction of phenylbutazone with racemic phenprocoumon and its enantiomers in rats. J. Pharmacokin. Biopharm. 7, 643–663 (1979).CrossRefGoogle Scholar
  17. Trenk, D., Jähnchen, E.: Effect of serum protein binding on pharmacokinetics and anticoagulant activity of phenprocoumon in rats. J. Pharmacokin. Biopharm. 8, 177–191 (1979).CrossRefGoogle Scholar
  18. Wagner, F., Jähnchen, E., Trenk, D., Eichelbaum, M., Har-Nasch, F., Häuf, G., Roskamm, H.: Severe complications of antianginal drug therapy in a patient identified as a poor metabolizer of metoprolol, propafenone, diltiazem and spartein. Klin. Wschr. 65, 1164–1168 (1987).PubMedCrossRefGoogle Scholar
  19. Wilkinson, G.R., Shand, D.G.: A physiological approach to hepatic drug clearance. Clin. Pharmacol. Ther. 18, 377–390 (1975).PubMedGoogle Scholar
  20. Woosley, R.L., Kronhauser, D., Smith, R., Reele, S., Higgins, S.B., Nies, A.S., Shand, D.G., Oates, J. A.: Suppression of chronic ventricular arrhythmias with propranolol. Circulation 60, 819–827 (1979).PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • D. Trenk
  • E. Jähnchen

There are no affiliations available

Personalised recommendations